Skip to search.
 TSX Down 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
25.88 Down 0.70(2.63%) 4:00PM EDT
|After Hours : 25.88 Down 0.00 (0.01%) 5:09PM EDT
Add to Portfolio
Prev Close:26.58
Open:26.51
Bid:25.86 x 400
Ask:26.10 x 3000
1y Target Est:43.29
Beta:0.05
Earnings Date:May 7 - May 8 (Est.)
Day's Range:25.56 - 26.61
52wk Range:12.43 - 39.68
Volume:1,638,721
Avg Vol (3m):1,963,350
Market Cap:2.66B
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NPSPDown 2.63%2.66B
ABT 0.00%59.56B
BIIBUp 0.18%72.51B

Key Statistics

Forward P/E (1 yr):19.03
P/S (ttm):17.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.19
Quarterly EPS Est (Mar-14) :-0.02
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):1.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback